Skip to main content

Sars-Cov-2 (Covid-19) Mrna-1273 (6M-5Y Bivalent Booster) Vaccine Dosage

Applies to the following strengths: preservative-free

Usual Pediatric Dose for:

Additional dosage information:

Usual Pediatric Dose for COVID-19

For investigational use only

6 months to 5 years:


Use: Active immunization to prevent COVID-19 caused by SARS-CoV-2 (SARS-CoV-2) original and Omicron BA.4/BA.5

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available


CONTRAINDICATIONS: Patients with known history of severe allergic reaction to the active component or any of the ingredients.

Safety and efficacy have not been established in patients younger than 6 months.


Data not available

Other Comments

Administration advice:

Storage requirements:

Reconstitution/preparation techniques:


Patient advice:

More about sars-cov-2 (covid-19) mrna-1273 (6m-5y bivalent booster) vaccine

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.